{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:59:26Z","timestamp":1781614766085,"version":"3.54.5"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001734","name":"Copenhagen University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001734","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s13346-025-01977-8","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T16:25:29Z","timestamp":1759940729000},"page":"1773-1787","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of sodium caprate dosed as a mini-tablet or suspension on insulin delivery and mucosa histomorphology"],"prefix":"10.1007","volume":"16","author":[{"given":"Freja","family":"Fredholt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8470-5144","authenticated-orcid":false,"given":"Joanne","family":"Heade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8211-5607","authenticated-orcid":false,"given":"Jukka","family":"Rantanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9149-6061","authenticated-orcid":false,"given":"Stine","family":"R\u00f8nholt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7285-9100","authenticated-orcid":false,"given":"Hanne M\u00f8rck","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"key":"1977_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0378-5173(03)00376-4","volume":"266","author":"DJA Crommelin","year":"2003","unstructured":"Crommelin DJA, Storm G, Verrijk R, De Leede L, Jiskoot W, Hennink WE. Shifting paradigms: biopharmaceuticals versus low molecular weight drugs. Int J Pharm. 2003;266:3\u201316. https:\/\/doi.org\/10.1016\/S0378-5173(03)00376-4.","journal-title":"Int J Pharm"},{"key":"1977_CR2","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.drudis.2021.01.001","volume":"26","author":"SK Dubey","year":"2021","unstructured":"Dubey SK, Parab S, Dabholkar N, Agrawal M, Singhvi G, Alexander A, et al. Oral peptide delivery: challenges and the way ahead. Drug Discov Today. 2021;26:931\u201350. https:\/\/doi.org\/10.1016\/j.drudis.2021.01.001.","journal-title":"Drug Discov Today"},{"key":"1977_CR3","doi-asserted-by":"publisher","first-page":"e202214795","DOI":"10.1002\/anie.202214795","volume":"62","author":"Y Yang","year":"2023","unstructured":"Yang Y, Zhou R, Wang Y, Zhang Y, Yu J, Gu Z. Recent advances in oral and transdermal protein delivery systems. Angew Chem. 2023;62:e202214795. https:\/\/doi.org\/10.1002\/anie.202214795.","journal-title":"Angew Chem"},{"key":"1977_CR4","doi-asserted-by":"publisher","first-page":"122238","DOI":"10.1016\/j.ijpharm.2022.122238","volume":"628","author":"S Berg","year":"2022","unstructured":"Berg S, Edlund H, Goundry RF, Bergstr\u00f6m WAS, Davies C. Considerations in the developability of peptides for oral administration when formulated together with transient permeation enhancers. Int J Pharm. 2022;628:122238. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.122238.","journal-title":"Int J Pharm"},{"key":"1977_CR5","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.addr.2016.06.005","volume":"106","author":"S Maher","year":"2016","unstructured":"Maher S, Mrsny RJ, Brayden DJ. Intestinal permeation enhancers for oral peptide delivery. Adv Drug Deliv Rev. 2016;106:277\u2013319. https:\/\/doi.org\/10.1016\/j.addr.2016.06.005.","journal-title":"Adv Drug Deliv Rev"},{"key":"1977_CR6","unstructured":"European Medicines Agency (EMA). Rybelsus; Summary of Product Characteristics. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/rybelsus-epar-product-information_en.pdf. Accessed September 2025."},{"key":"1977_CR7","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s40262-018-0728-4","volume":"58","author":"C Granhall","year":"2019","unstructured":"Granhall C, Donsmark M, Blicher TM, Golor G, S\u00f8ndergaard FL, Thomsen M, et al. Safety and pharmacokinetics of single and multiple ascending doses of the novel oral human GLP-1 analogue, oral semaglutide, in healthy subjects and subjects with type 2 diabetes. Clin Pharmacokinet. 2019;58:781\u201391. https:\/\/doi.org\/10.1007\/s40262-018-0728-4.","journal-title":"Clin Pharmacokinet"},{"key":"1977_CR8","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s40262-021-01025-x","volume":"60","author":"RV Overgaard","year":"2021","unstructured":"Overgaard RV, Navarria A, Ingwersen SH, B\u00e6kdal TA, Kildemoes RJ. Clinical pharmacokinetics of oral semaglutide: analyses of data from clinical Pharmacology trials. Clin Pharmacokinet. 2021;60:1335\u201348. https:\/\/doi.org\/10.1007\/s40262-021-01025-x.","journal-title":"Clin Pharmacokinet"},{"key":"1977_CR9","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1021\/acs.molpharmaceut.2c00443","volume":"20","author":"H Tran","year":"2023","unstructured":"Tran H, Aihara E, Mohammed FA, Qu H, Riley A, Su Y, et al. In vivo mechanism of action of sodium Caprate for improving the intestinal absorption of a GLP1\/GIP coagonist peptide. Mol Pharm. 2023;20:929\u201341. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.2c00443.","journal-title":"Mol Pharm"},{"key":"1977_CR10","doi-asserted-by":"publisher","first-page":"105685","DOI":"10.1016\/j.ejps.2020.105685","volume":"158","author":"C Twarog","year":"2021","unstructured":"Twarog C, McCartney F, Harrison SM, Illel B, Fattal E, Brayden DJ. Comparison of the effects of the intestinal permeation enhancers, SNAC and sodium Caprate (C10): isolated rat intestinal mucosae and sacs. Eur J Pharm Sci. 2021;158:105685. https:\/\/doi.org\/10.1016\/j.ejps.2020.105685.","journal-title":"Eur J Pharm Sci"},{"key":"1977_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ejpb.2020.04.023","volume":"152","author":"C Twarog","year":"2020","unstructured":"Twarog C, Liu K, O\u2019Brien PJ, Dawson KA, Fattal E, Illel B, et al. A head-to-head Caco-2 assay comparison of the mechanisms of action of the intestinal permeation enhancers: SNAC and sodium Caprate (C10). Eur J Pharm Biopharm. 2020;152:95\u2013107. https:\/\/doi.org\/10.1016\/j.ejpb.2020.04.023.","journal-title":"Eur J Pharm Biopharm"},{"key":"1977_CR12","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1007\/s40262-019-00772-2","volume":"58","author":"IB Halberg","year":"2019","unstructured":"Halberg IB, Lyby K, Wassermann K, Heise T, Plum-M\u00f6rschel L, Zijlstra E. The effect of food intake on the pharmacokinetics of oral basal insulin: A randomised crossover trial in healthy male subjects. Clin Pharmacokinet. 2019;58:1497\u2013504. https:\/\/doi.org\/10.1007\/s40262-019-00772-2.","journal-title":"Clin Pharmacokinet"},{"key":"1977_CR13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S2213-8587(18)30372-3","volume":"7","author":"IB Halberg","year":"2019","unstructured":"Halberg IB, Lyby K, Wassermann K, Heise T, Zijlstra E, Plum-M\u00f6rschel L. Efficacy and safety of oral basal insulin versus subcutaneous insulin glargine in type 2 diabetes: a randomised, double-blind, phase 2 trial. Lancet Diabetes Endocrinol. 2019;7:179\u201388. https:\/\/doi.org\/10.1016\/S2213-8587(18)30372-3.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1977_CR14","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/jps.21084","volume":"97","author":"LG Tillman","year":"2008","unstructured":"Tillman LG, Geary RS, Hardee GE. Oral delivery of antisense oligonucleotides in man. J Pharm Sci. 2008;97:225\u201336. https:\/\/doi.org\/10.1002\/jps.21084.","journal-title":"J Pharm Sci"},{"key":"1977_CR15","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ejps.2009.07.011","volume":"38","author":"S Maher","year":"2009","unstructured":"Maher S, Wang X, Bzik V, McClean S, Brayden DJ. Evaluation of intestinal absorption and mucosal toxicity using two promoters. II. Rat instillation and perfusion studies. Eur J Pharm Sci. 2009;38:301\u201311. https:\/\/doi.org\/10.1016\/j.ejps.2009.07.011.","journal-title":"Eur J Pharm Sci"},{"key":"1977_CR16","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1021\/acs.molpharmaceut.1c00724","volume":"19","author":"S Berg","year":"2022","unstructured":"Berg S, K\u00e4rrberg L, Suljovic D, Seeliger F, S\u00f6derberg M, Perez-Alcazar M, et al. Impact of intestinal concentration and colloidal structure on the permeation-enhancing efficiency of sodium Caprate in the rat. Mol Pharm. 2022;19:200\u201312. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.1c00724.","journal-title":"Mol Pharm"},{"key":"1977_CR17","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1021\/acs.molpharmaceut.2c00261","volume":"19","author":"S Berg","year":"2022","unstructured":"Berg S, Suljovic D, K\u00e4rrberg L, Englund M, B\u00f6nisch H, Karlberg I, et al. Intestinal absorption of FITC-dextrans and macromolecular model drugs in the rat intestinal instillation model. Mol Pharm. 2022;19:2564\u201372. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.2c00261.","journal-title":"Mol Pharm"},{"key":"1977_CR18","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.jconrel.2022.12.011","volume":"353","author":"S Berg","year":"2023","unstructured":"Berg S, Uggla T, Antonsson M, Nunes SF, Englund M, Rosengren L, et al. Evaluation in pig of an intestinal administration device for oral peptide delivery. J Control Release. 2023;353:792\u2013801. https:\/\/doi.org\/10.1016\/j.jconrel.2022.12.011.","journal-title":"J Control Release"},{"key":"1977_CR19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jconrel.2017.09.025","volume":"268","author":"S Harloff-Helleberg","year":"2017","unstructured":"Harloff-Helleberg S, Nielsen LH, Nielsen HM. Animal models for evaluation of oral delivery of biopharmaceuticals. J Control Release. 2017;268:57\u201371. https:\/\/doi.org\/10.1016\/j.jconrel.2017.09.025.","journal-title":"J Control Release"},{"key":"1977_CR20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3390\/pharmaceutics12010081","volume":"12","author":"N G\u00f3mez-Lado","year":"2020","unstructured":"G\u00f3mez-Lado N, Seoane-Via\u00f1o I, Matiz S, Madla CM, Yadav V, Aguiar P, et al. Gastrointestinal tracking and gastric emptying of coated capsules in rats with or without sedation using CT imaging. Pharmaceutics. 2020;12:81. https:\/\/doi.org\/10.3390\/pharmaceutics12010081.","journal-title":"Pharmaceutics"},{"key":"1977_CR21","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ijpharm.2010.01.001","volume":"388","author":"S Saphier","year":"2010","unstructured":"Saphier S, Rosner A, Brandeis R, Karton Y. Gastro intestinal tracking and gastric emptying of solid dosage forms in rats using X-ray imagining. Int J Pharm. 2010;388:190\u20135. https:\/\/doi.org\/10.1016\/j.ijpharm.2010.01.001.","journal-title":"Int J Pharm"},{"key":"1977_CR22","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.ijpharm.2011.10.017","volume":"422","author":"N Reix","year":"2012","unstructured":"Reix N, Guhmann P, Bietiger W, Pinget M, Jeandidier N, Sigrist S. Duodenum-specific drug delivery: in vivo assessment of a pharmaceutically developed enteric-coated capsule for a broad applicability in rat studies. Int J Pharm. 2012;422:338\u201340. https:\/\/doi.org\/10.1016\/j.ijpharm.2011.10.017.","journal-title":"Int J Pharm"},{"key":"1977_CR23","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1007\/s11095-017-2129-z","volume":"34","author":"D Markl","year":"2017","unstructured":"Markl D, Zeitler JA. A review of disintegration mechanisms and measurement techniques. Pharm Res. 2017;34:890\u2013917. https:\/\/doi.org\/10.1007\/s11095-017-2129-z.","journal-title":"Pharm Res"},{"key":"1977_CR24","doi-asserted-by":"publisher","first-page":"763","DOI":"10.3109\/10837450.2015.1045618","volume":"21","author":"J Quodbach","year":"2016","unstructured":"Quodbach J, Kleinebudde P. A critical review on tablet disintegration. Pharm Dev Technol. 2016;21:763\u201374. https:\/\/doi.org\/10.3109\/10837450.2015.1045618.","journal-title":"Pharm Dev Technol"},{"key":"1977_CR25","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1080\/03639045.2017.1397685","volume":"44","author":"K Zaheer","year":"2018","unstructured":"Zaheer K, Langguth P. Formulation strategy towards minimizing viscosity mediated negative food effect on disintegration and dissolution of immediate release tablets. Drug Dev Ind Pharm. 2018;44:444\u201351. https:\/\/doi.org\/10.1080\/03639045.2017.1397685.","journal-title":"Drug Dev Ind Pharm"},{"key":"1977_CR26","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1111\/j.1365-2036.2005.02683.x","volume":"22","author":"C Schiller","year":"2005","unstructured":"Schiller C, Fr\u00f6hlich CP, Giessmann T, Siegmund W, M\u00f6nnikes H, Hosten N, Weitschies W. Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging. Aliment Pharmacol Ther. 2005;22:971\u20139. https:\/\/doi.org\/10.1111\/j.1365-2036.2005.02683.x.","journal-title":"Aliment Pharmacol Ther"},{"key":"1977_CR27","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1211\/jpp.60.1.0008","volume":"60","author":"EL McConnell","year":"2008","unstructured":"McConnell EL, Basit AW, Murdan S. Measurements of rat and mouse Gastrointestinal pH, fluid and lymphoid tissue, and implications for in-vivo experiments. J Pharm Pharmacol. 2008;60:63\u201370. https:\/\/doi.org\/10.1211\/jpp.60.1.0008.","journal-title":"J Pharm Pharmacol"},{"key":"1977_CR28","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jconrel.2021.07.030","volume":"338","author":"RG Diedrichsen","year":"2021","unstructured":"Diedrichsen RG, Harloff-Helleberg S, Werner U, Besenius M, Leberer E, Kristensen M, et al. Revealing the importance of carrier-cargo association in delivery of insulin and lipidated insulin. J Control Release. 2021;338:8\u201321.","journal-title":"J Control Release"},{"key":"1977_CR29","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.powtec.2011.12.060","volume":"238","author":"KG Pitt","year":"2013","unstructured":"Pitt KG, Heasley MG. Determination of the tensile strength of elongated tablets. Powder Technol. 2013;238:169\u201375. https:\/\/doi.org\/10.1016\/j.powtec.2011.12.060.","journal-title":"Powder Technol"},{"key":"1977_CR30","doi-asserted-by":"publisher","unstructured":"Raptis K, Heade J, Cunha C, van de Weert M, Saaby L, R\u00f8nholt S, et al. Permeation enhancer-based ionogel shows remarkable potential for oral insulin delivery. Adv Healthc Mater. 2025;e2500946. https:\/\/doi.org\/10.1002\/adhm.202500946.","DOI":"10.1002\/adhm.202500946"},{"key":"1977_CR31","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ejpb.2019.07.007","volume":"142","author":"JF Christfort","year":"2019","unstructured":"Christfort JF, Strindberg S, Plum J, Hall-Andersen J, Janfelt C, Nielsen LH, et al. Developing a predictive in vitro dissolution model based on Gastrointestinal fluid characterisation in rats. Eur J Pharm Biopharm. 2019;142:307\u201314. https:\/\/doi.org\/10.1016\/j.ejpb.2019.07.007.","journal-title":"Eur J Pharm Biopharm"},{"key":"1977_CR32","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.biomaterials.2012.09.051","volume":"34","author":"SM Krug","year":"2013","unstructured":"Krug SM, Amasheh M, Dittmann I, Christoffel I, Fromm M, Amasheh S. Sodium Caprate as an enhancer of macromolecule permeation across tricellular tight junctions of intestinal cells. Biomaterials. 2013;34:275\u201382. https:\/\/doi.org\/10.1016\/j.biomaterials.2012.09.051.","journal-title":"Biomaterials"},{"key":"1977_CR33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0376-7388(94)00230-V","volume":"100","author":"A Fick","year":"1995","unstructured":"Fick A. On liquid diffusion. J Membr Sci. 1995;100:33\u20138. https:\/\/doi.org\/10.1016\/0376-7388(94)00230-V.","journal-title":"J Membr Sci"},{"key":"1977_CR34","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s11743-001-0189-x","volume":"9","author":"B Luepakdeesakoon","year":"2006","unstructured":"Luepakdeesakoon B, Saiwan C, Scamehorn JF. Contact angle of surfactant solutions on precipitated surfactant surfaces. III. Effects of subsaturated anionic and nonionic surfactants and NaCl. J Surfact Deterg. 2006;9:125\u201336. https:\/\/doi.org\/10.1007\/s11743-001-0189-x.","journal-title":"J Surfact Deterg"},{"key":"1977_CR35","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1208\/s12248-008-9057-0","volume":"10","author":"DF Steele","year":"2008","unstructured":"Steele DF, Moreton RC, Staniforth JN, Young PM, Tobyn MJ, Edge S. Surface energy of microcrystalline cellulose determined by capillary intrusion and inverse gas chromatography. AAPS J 8 Oktober. 2008;10:494\u2013503. https:\/\/doi.org\/10.1208\/s12248-008-9057-0.","journal-title":"AAPS J 8 Oktober"},{"key":"1977_CR36","doi-asserted-by":"publisher","first-page":"460","DOI":"10.18433\/J3K31N","volume":"18","author":"Y Miyazaki","year":"2015","unstructured":"Miyazaki Y, Miyawaki K, Uchino T, Kagawa Y. Dry powder coating using planetary centrifugal mixer. J Pharm Pharm Sci. 2015;18:460\u201373. https:\/\/doi.org\/10.18433\/J3K31N.","journal-title":"J Pharm Pharm Sci"},{"key":"1977_CR37","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.5c00249","author":"A Fagan","year":"2025","unstructured":"Fagan A, Bateman LM, Crean AM, O\u2019Shea JP, Taylor LS. Impact of permeation enhancers on the release of insulin from tablets in biorelevant media. Mol Pharm. 2025. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.5c00249. Article ASAP.","journal-title":"Mol Pharm"},{"key":"1977_CR38","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.jconrel.2003.12.017","volume":"95","author":"AH Krauland","year":"2004","unstructured":"Krauland AH, Guggi D, Bernkop-Schn\u00fcrch A. Oral insulin delivery: the potential of thiolated chitosan-insulin tablets on non-diabetic rats. J Control Release. 2004;95:547\u201355. https:\/\/doi.org\/10.1016\/j.jconrel.2003.12.017.","journal-title":"J Control Release"},{"key":"1977_CR39","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1002\/jps.24102","volume":"103","author":"G Millotti","year":"2014","unstructured":"Millotti G, Laffleur F, Perera G, Vigl C, Pickl K, Sinner F, et al. In vivo evaluation of thiolated Chitosan tablets for oral insulin delivery. J Pharm Sci. 2014;103:3165\u201370. https:\/\/doi.org\/10.1002\/jps.24102.","journal-title":"J Pharm Sci"},{"key":"1977_CR40","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1021\/bm700916h","volume":"9","author":"B Deutel","year":"2008","unstructured":"Deutel B, Greindl M, Thaurer M, Bernkop-Schn\u00fcrch A. Novel insulin thiomer nanoparticles: in vivo evaluation of an oral drug delivery system. Biomacromolecules. 2008;9:278\u201385. https:\/\/doi.org\/10.1021\/bm700916h.","journal-title":"Biomacromolecules"},{"key":"1977_CR41","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1080\/10611860701349141","volume":"15","author":"M Werle","year":"2007","unstructured":"Werle M, Loretz B, Entstrasser D, F\u00f6ger F. Design and evaluation of a chitosan-aprotinin conjugate for the peroral delivery of therapeutic peptides and proteins susceptible to enzymatic degradation. J Drug Target. 2007;15:327\u201333. https:\/\/doi.org\/10.1080\/10611860701349141.","journal-title":"J Drug Target"},{"key":"1977_CR42","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ejpb.2016.08.002","volume":"108","author":"A Maroni","year":"2016","unstructured":"Maroni A, Del Curto MD, Salmaso S, Zema L, Melocchi A, Caliceti P, et al. In vitro and in vivo evaluation of an oral multiple-unit formulation for colonic delivery of insulin. Eur J Pharm Biopharm. 2016;108:76\u201382. https:\/\/doi.org\/10.1016\/j.ejpb.2016.08.002.","journal-title":"Eur J Pharm Biopharm"},{"key":"1977_CR43","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/j.addr.2009.09.006","volume":"61","author":"S Maher","year":"2009","unstructured":"Maher S, Leonard TW, Jacobsen J, Brayden DJ. Safety and efficacy of sodium Caprate in promoting oral drug absorption: from in vitro to the clinic. Adv Drug Deliv Rev. 2009;61:1427\u201349. https:\/\/doi.org\/10.1016\/j.addr.2009.09.006.","journal-title":"Adv Drug Deliv Rev"},{"key":"1977_CR44","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1517\/17425247.3.5.685","volume":"3","author":"TW Leonard","year":"2006","unstructured":"Leonard TW, Lynch J, McKenna MJ, Brayden DJ. Promoting absorption of drugs in humans using medium-chain fatty acid-based solid dosage forms: GIPET. Expert Opin Drug Deliv. 2006;3:685\u201392. https:\/\/doi.org\/10.1517\/17425247.3.5.685.","journal-title":"Expert Opin Drug Deliv"},{"key":"1977_CR45","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0928-0987(02)00162-8","volume":"17","author":"AA Raoof","year":"2002","unstructured":"Raoof AA, Ramtoola Z, McKenna B, Yu RZ, Hardee G, Geary RS. Effect of sodium Caprate on the intestinal absorption of two modified antisense oligonucleotides in pigs. Eur J Pharm Sci. 2002;17:131\u20138. https:\/\/doi.org\/10.1016\/S0928-0987(02)00162-8.","journal-title":"Eur J Pharm Sci"},{"key":"1977_CR46","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1023\/A:1012112219578","volume":"14","author":"T Lindmark","year":"1997","unstructured":"Lindmark T, S\u00f6derholm JD, Olaison G, Alv\u00e1n G, Ocklind G, Artursson P. Mechanism of absorption enhancement in humans after rectal administration of ampicillin in suppositories containing sodium Caprate. Pharm Res. 1997;14:930\u201355. https:\/\/doi.org\/10.1023\/A:1012112219578.","journal-title":"Pharm Res"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01977-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-025-01977-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01977-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:29:03Z","timestamp":1781612943000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-025-01977-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1977"],"URL":"https:\/\/doi.org\/10.1007\/s13346-025-01977-8","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,8]]},"assertion":[{"value":"3 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with all institutional and national guidelines for the care and use of laboratory animals. Data were obtained under license number 2021-15-0201-00856 approved by the Danish Animal Experiments 31 Inspectorate and in compliance with Danish laws regulating experiments on animals and EU directive 2010\/63\/EU. No human participants, their data or biological material were used by the authors for this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors give consent for publication. No human participants, their data or biological material were a included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare that they have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}